KEYTRUDA COST - AN OVERVIEW

Overview Pembrolizumab (Keytruda): CADTH Reimbursement Suggestion: Indicator: In combination with chemotherapy, to the procedure of adult individuals with domestically recurrent unresectable or metastatic triple-unfavorable breast most cancers which have not been given prior chemotherapy for metastatic disease and whose tumours Categorical programm